ScholarIQanswers from OpenAlex

Integrin-targeted paclitaxel nanoliposomes for tumor therapy

PaperCitations, authors & open-access status

Integrin-targeted paclitaxel nanoliposomes for tumor therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Integrin-targeted paclitaxel nanoliposomes for tumor therapy have?

ScholarIQcitation count

Integrin-targeted paclitaxel nanoliposomes for tumor therapy has 53 citations in the OpenAlex counts ScholarIQ stores.

When was Integrin-targeted paclitaxel nanoliposomes for tumor therapy published?

ScholarIQyear

Integrin-targeted paclitaxel nanoliposomes for tumor therapy has 2010 year in the ScholarIQ index.

What is the open-access status of Integrin-targeted paclitaxel nanoliposomes for tumor therapy?

ScholarIQoa status

Integrin-targeted paclitaxel nanoliposomes for tumor therapy has closed oa status in the ScholarIQ index.

What is the DOI of Integrin-targeted paclitaxel nanoliposomes for tumor therapy?

ScholarIQdoi

The DOI for Integrin-targeted paclitaxel nanoliposomes for tumor therapy is on the source record.

What is the PMID of Integrin-targeted paclitaxel nanoliposomes for tumor therapy?

ScholarIQpmid

The PMID for Integrin-targeted paclitaxel nanoliposomes for tumor therapy is on the source record.

What is the OpenAlex record for Integrin-targeted paclitaxel nanoliposomes for tumor therapy?

ScholarIQopenalex

The OpenAlex for Integrin-targeted paclitaxel nanoliposomes for tumor therapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial